Treatment of human disease due to Mycobacterium bovis: a systematic review

Eur Respir J. 2016 Nov;48(5):1500-1503. doi: 10.1183/13993003.00629-2016. Epub 2016 Aug 18.

Authors

Zhiyi Lan¹, Mayara Bastos², Dick Menzies³

Affiliations

¹ Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill University, Montreal, QC, Canada.
² Dept of Infectious Diseases, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
³ Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill University, Montreal, QC, Canada dick.menzies@mcgill.ca.

PMID: 27540021
DOI: 10.1183/13993003.00629-2016

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Review
Systematic Review

MeSH terms

Adult
Animals
Antitubercular Agents / therapeutic use*
Female
Humans
Male
Middle Aged
Mycobacterium bovis / drug effects*
Mycobacterium bovis / pathogenicity
Treatment Outcome
Tuberculosis / drug therapy*
Tuberculosis / transmission

Substances

Antitubercular Agents